Statements issued by Wellcome in response to the Covid-19 pandemic.
People from Black and Asian minority ethnic (BAME) groups in Britain were far more likely than their White counterparts to be very concerned about the impact of coronavirus on their personal finances, physical and mental health at the height of lockdown, and less trusting of information on the disease from health sector and government sources, according to a new Wellcome survey.
The Wellcome Photography Prize has announced its 2020 shortlist.
Our Director Jeremy Farrar responds to an open letter from more than 300 Black, Asian and minority ethnic academics, calling for racial justice in UK higher education.
Statement on the end of the Ebola epidemic in the eastern Democratic Republic of Congo
A statement from Wellcome’s Executive Leadership Team on diversity and inclusion.
Statement from Wellcome in response to the UK Government announcement that the Department for International Development (DfID) will be merged with the Foreign Office
Statement from Wellcome on Johnson & Johnson Ebola vaccine recommended for approval by the European Medicines Agency
US public overwhelmingly support equitable global access to COVID-19 vaccines and treatments.
Ensuring the people who most need access to vaccines and effective treatments against Covid-19, wherever they are in the world, is supported by almost 9 in 10 German adults.
A YouGov poll, commissioned by Wellcome, reveals that 9 in 10 people (90%) in the UK say COVID-19 treatments and vaccines should first be provided for those who need them most in the world.
Julia Gillard has been appointed as the next Chair of Wellcome, succeeding Eliza Manningham-Buller. The former Prime Minister of Australia will take up her new role in April 2021 when Baroness Manningham-Buller steps down from the Board of Governors.
Wellcome has announced the first group of businesses and philanthropists to pledge funds through COVID-Zero, a coalition supporting research and development into vaccines, treatments and tests for COVID-19.
Wellcome has launched an initiative, COVID-Zero, to help raise at least $8 billion by the end of April to cover a global funding shortfall for vaccines, treatments and testing for coronavirus.
Researchers at three institutions in the US and UK receive grants to advance studies of repurposed drugs and novel antibodies in preventing COVID-19.
More than 30 leading publishers have committed to making all of their COVID-19 and coronavirus-related publications, and the available data supporting them, immediately accessible in PubMed Central and other public repositories.
COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic.
We call on researchers, journals and funders to ensure that research findings and data relevant to this outbreak are shared rapidly and openly to inform the public health response and help save lives.
Jeremy Farrar, Wellcome's Director, pays tribute to Dr Peter Salama, an Executive Director at the WHO who was instrumental in leading efforts to tackle Ebola.
Wellcome Trust survey on research culture in the UK and globally exposes the stark pressures faced by many who work in research.